{
    "title": "103_hr5253",
    "content": "The \"Medical Malpractice Reform Act of 1994\" is cited as the short title. It addresses the calculation and payment of damages in medical malpractice claims and actions. The \"Medical Malpractice Reform Act of 1994\" limits noneconomic damages in medical malpractice cases to $250,000. Damages received will be reduced by any other compensation for the same injury. The \"Medical Malpractice Reform Act of 1994\" limits noneconomic damages in medical malpractice cases to $250,000 and reduces damages received by any other compensation for the same injury. In cases where future economic damages exceed a certain amount, periodic payments may be made for future losses. In cases where future economic damages exceed $100,000, a defendant may make periodic payments based on when the damages are likely to occur, as determined by the court. The court may waive this requirement if it is not in the best interests of the plaintiff to receive payments periodically. LIMITATION ON ATTORNEYS' CONTINGENCY FEES AND OTHER COSTS UNDER MEDICAL MALPRACTICE CLAIMS. Attorneys representing claimants in medical malpractice liability claims on a contingency fee basis are limited in the fees they can charge. The fee cannot exceed 25% of the first $150,000 recovered, plus 10% of any amount over $150,000. If the judgment or settlement includes periodic payments, the fee is based on the cost of the annuity or trust set up for the payments. If no annuity or trust is established, the fee is based on the present value of the payments. SEC. 4. APPLICABILITY; EFFECT ON STATE LAW. This Act applies to medical malpractice liability claims in State or Federal courts, preempting inconsistent State laws but not those with greater limitations on damages or attorney fees. It does not affect sovereign immunity defenses. The Act does not waive sovereign immunity defenses for States or the United States, nor does it affect the Foreign Sovereign Immunities Act. It also does not preempt State choice-of-law rules for claims by foreign nations or citizens, or impact court jurisdiction over medical malpractice claims. The Act does not affect court jurisdiction over medical malpractice liability actions in district courts of the United States under section 1331 or 1337 of title 28, United States Code. SEC. 5. DEFINITIONS. In this Act, the term \"claimant\" refers to individuals alleging medical malpractice liability claims. \"Economic damages\" are payments for medical expenses, lost wages, and other financial losses. A \"health care professional\" is someone licensed to provide healthcare services in a State. The term \"health care provider\" refers to organizations or institutions delivering health care services in a State, required to be licensed or certified. \"Injury\" is defined as any illness, disease, or harm in a medical malpractice liability action. A \"medical malpractice liability action\" is a civil lawsuit against a health care provider alleging malpractice. A medical malpractice liability claim involves alleging injury caused by health care services or medical products, excluding intentional tort actions. The term \"medical product\" refers to drugs or medical devices as defined by the Federal Food, Drug, and Cosmetic Act. The Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(h)) outlines conditions under which a drug or device is subject to premarket approval by the FDA. The term \"medical product\" excludes products approved by the FDA due to withheld information, misrepresentation, or illegal payments. Noneconomic damages are also defined. Noneconomic damages are damages paid to compensate for physical and emotional pain, suffering, and other nonpecuniary losses. Punitive damages are awarded to punish malicious or reckless conduct. The term \"State\" includes various regions within the United States. The Act applies to claims and actions after its enactment."
}